Diacerein

Description: Diacerein (Fisiodar) is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including sevre diarrhea [L780]. Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications. Target: Interleukin, IL Receptor. Smiles: CC(=O)OC1=CC(=CC2=C1C(=O)C1=C(OC(C)=O)C=CC=C1C2=O)C(O)=O. References: Yaron M, et al. Osteoarthritis Cartilage, 1999, 7(3), 272-280.